Multi-Organ Transplant AlloSure Monitoring Market : Global Industry Analysis and Opportunity Assessment, 2036

Future Market Insights

Multi-Organ Transplant AlloSure Monitoring Market

Key Insight

The donor-derived cell-free DNA (dd-cfDNA) monitoring segment leads the multi-organ transplant AlloSure monitoring market by test type with a 32.6% share in 2026. Kidney transplantation accounts for 44.4% by organ type, acute rejection monitoring holds 37.9% by application, and transplant centers represent 30.8% by end user.

July 29, 2026

Anurag Sharma

250 Pages

Cite this Report

Multi-Organ Transplant AlloSure Monitoring Market

https://www.futuremarketinsights.com/reports/multi-organ-transplant-allosure-monitoring-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

CareDx
Natera
Eurofins Transplant Genomics
Thermo Fisher Scientific
Devyser Diagnostics
Insight Molecular Diagnostics
Bio-Rad Laboratories
Verici Dx

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Multi-Organ Transplant AlloSure Monitoring Market

Key Players

Similar Industry Reports